Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bolt Biotherapeutics, Inc. (BOLT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bolt Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1641281.
Total stock buying since 2021: $37,200,150.
Total stock sales since 2021: $1,868,437.
Total stock option exercises since 2021: $99,999.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 10,000 | $5,668 | 0 | $0 | 0 | $0 |
| 2023 | 11,829 | $11,241 | 289,454 | $259,397 | 0 | $0 |
| 2022 | 0 | $0 | 800,000 | $1,600,000 | 0 | $0 |
| 2021 | 1,863,684 | $37,183,241 | 452 | $9,040 | 35,714 | $99,999 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 5,000 | $2,484 | 0 | $0 | 0 | $0 |
| 2024-06 | 5,000 | $3,184 | 0 | $0 | 0 | $0 |
| 2023-12 | 10,000 | $9,080 | 0 | $0 | 0 | $0 |
| 2023-11 | 0 | $0 | 289,454 | $259,397 | 0 | $0 |
| 2023-06 | 1,829 | $2,161 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 800,000 | $1,600,000 | 0 | $0 |
| 2021-12 | 5,446 | $25,644 | 0 | $0 | 35,714 | $99,999 |
| 2021-06 | 2,138 | $35,597 | 0 | $0 | 0 | $0 |
| 2021-02 | 1,856,100 | $37,122,000 | 452 | $9,040 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-16 | Nemec Sarah (Senior VP, Finance and PAO) | Buy | 2,500 | .50 | 1,242 |
| 2024-12-16 | Quinn William P. (President, CEO and CFO) | Buy | 2,500 | .50 | 1,242 |
| 2024-06-06 | Nemec Sarah (Senior VP, Finance and PAO) | Buy | 2,500 | .64 | 1,592 |
| 2024-06-06 | Quinn William P. (President, CEO and CFO) | Buy | 2,500 | .64 | 1,592 |
| 2023-12-12 | Quinn William P. (Chief Financial Officer) | Buy | 7,500 | .95 | 7,125 |
| 2023-12-06 | Quinn William P. (Chief Financial Officer) | Buy | 2,500 | .78 | 1,955 |
| 2023-11-30 | Engleman Edgar (Director) | Sale | 123,079 | .86 | 105,601 |
| 2023-11-29 | Engleman Edgar (Director) | Sale | 25,805 | .91 | 23,379 |
| 2023-11-21 | Vivo Panda Fund, L.p. | Sale | 3,400 | .90 | 3,060 |
| 2023-11-21 | Engleman Edgar (Director) | Sale | 1,943 | .90 | 1,750 |
| 2023-11-20 | Vivo Panda Fund, L.p. | Sale | 54,700 | .92 | 50,324 |
| 2023-11-20 | Engleman Edgar (Director) | Sale | 31,257 | .92 | 28,756 |
| 2023-11-17 | Vivo Panda Fund, L.p. | Sale | 16,354 | .93 | 15,209 |
| 2023-11-17 | Engleman Edgar (Director) | Sale | 9,345 | .93 | 8,690 |
| 2023-11-16 | Vivo Panda Fund, L.p. | Sale | 15,000 | .96 | 14,400 |
| 2023-11-16 | Engleman Edgar (Director) | Sale | 8,571 | .96 | 8,228 |
| 2023-06-06 | Quinn William P. (Chief Financial Officer) | Buy | 1,829 | 1.18 | 2,161 |
| 2022-07-13 | Novo Holdings A/s (10% Owner) | Sale | 800,000 | 2.00 | 1,600,000 |
| 2021-12-22 | Perez Edith A. (Chief Medical Officer) | Option Ex | 35,714 | 2.80 | 99,999 |
| 2021-12-08 | Quinn William P. (Chief Financial Officer) | Buy | 5,000 | 4.71 | 23,575 |
| 2021-12-06 | Perez Edith A. (Chief Medical Officer) | Buy | 411 | 4.64 | 1,907 |
| 2021-12-06 | Quinn William P. (Chief Financial Officer) | Buy | 35 | 4.64 | 162 |
| 2021-06-04 | Perez Edith A. (Chief Medical Officer) | Buy | 917 | 16.65 | 15,268 |
| 2021-06-04 | Quinn William P. (Chief Financial Officer) | Buy | 1,221 | 16.65 | 20,329 |
| 2021-02-09 | Khanna Ashish Siri Ram (Director) | Buy | 2,200 | 20.00 | 44,000 |
| 2021-02-09 | Vivo Opportunity, Llc (10% Owner) | Buy | 350,000 | 20.00 | 7,000,000 |
| 2021-02-09 | Vivo Opportunity, Llc (10% Owner) | Sale | 226 | 20.00 | 4,520 |
| 2021-02-09 | Quinn William P. (Chief Financial Officer) | Buy | 1,200 | 20.00 | 24,000 |
| 2021-02-09 | Schatzman Randall C (Chief Executive Officer) | Buy | 1,500 | 20.00 | 30,000 |
| 2021-02-09 | Novo Holdings A/s (10% Owner) | Buy | 400,000 | 20.00 | 8,000,000 |
| 2021-02-09 | Shah Mahendra (Director) | Sale | 62 | 20.00 | 1,240 |
| 2021-02-09 | Healy James (Director) | Buy | 450,000 | 20.00 | 9,000,000 |
| 2021-02-09 | Engleman Edgar (Director) | Buy | 200,000 | 20.00 | 4,000,000 |
| 2021-02-09 | Engleman Edgar (Director) | Sale | 164 | 20.00 | 3,280 |
| 2021-02-09 | Powell Michael | Buy | 450,000 | 20.00 | 9,000,000 |
| 2021-02-09 | Laporte Kathleen (Director) | Buy | 1,200 | 20.00 | 24,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BOLT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bolt Biotherapeutics, Inc. (symbol BOLT, CIK number 1641281) see the Securities and Exchange Commission (SEC) website.